Nasdaq · Healthcare
Bowman Consulting Group Ltd. (BWMN)
As-reported financials and recent SEC filings for Bowman Consulting Group Ltd., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$490.0M
Net income
$12.8M
Net margin
2.6%
Diluted EPS
$0.73
ROE
4.9%
P/E (TTM)
48.3×
Market cap
$523.8M
Debt / equity
0.2×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $490.0M | $426.6M | $346.3M | $261.7M | $150.0M |
| Gross profit | $261.5M | $222.8M | $176.0M | $135.1M | $75.4M |
| Operating income | $19.7M | $-2.0M | $-656,000 | $5.1M | $160,000 |
| Net income | $12.8M | $3.0M | $-6.6M | $5.0M | $299,000 |
| Diluted EPS | $0.73 | $0.17 | $-0.53 | $0.37 | $0.03 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
32026-06-25
View on EDGAR →32026-06-25
View on EDGAR →42026-06-05
View on EDGAR →8-K2026-06-03
View on EDGAR →1442026-06-02
View on EDGAR →42026-05-29
View on EDGAR →42026-05-29
View on EDGAR →42026-05-29
View on EDGAR →Go deeper on BWMN
Search Bowman Consulting Group Ltd.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.